On 5 March 2021, the Office of the US Trade Representative (“USTR”) extended, once again, the expiration date of the temporary Section 301 tariff exclusions for COVID-19 medical care products. Specifically, the latest extension of the expiration of the exclusions that were announced last year has changed from 31 March 2021 to 30 September 2021.
The extension covers 99 product exclusions and can be applied to any medical materials that match the product exclusion descriptions set forth in prior exclusion announcements. According to the USTR, this decision was made to continue the fight against the COVID-19 pandemic.
On 31 December 2020, most exclusions from Section 301 tariffs on Chinese‐origin goods expired, with the sole exception of Section 301 tariffs applicable to certain medical care products needed as a result of the COVID-19 pandemic. The latest extensions for COVID-19-related medical care products were decided by the new federal administration after the USTR under the prior federal administration had extended the exclusions from 31 December 2020 to 31 March 2021.
Deloitte’s Global Trade Advisory specialists are part of a global network of professionals who can provide specialised assistance to companies in global trade matters. Our professionals can help companies seeking to manage the impacts and potential impacts of the developments described above by:
Meng Yew Wong